Beginning Cash: The amount of cash reported by the company on its previous statement.
Rapport Therapeutics, Inc. (RAPP) had Beginning Cash of $56.91M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-26.93M |
|
-- |
|
-- |
|
$29.99M |
|
$-29.99M |
|
$3.06M |
|
$-26.93M |
|
$-26.93M |
|
$-26.93M |
|
$-26.93M |
|
$-26.93M |
|
$-26.93M |
|
$-29.99M |
|
$-29.53M |
|
37.93M |
|
37.93M |
|
$-0.71 |
|
$-0.71 |
|
| Balance Sheet Financials | |
$520.66M |
|
$3.12M |
|
$14.66M |
|
$535.32M |
|
$14.32M |
|
-- |
|
$9.39M |
|
$23.71M |
|
$511.62M |
|
$511.62M |
|
$511.62M |
|
47.65M |
|
| Cash Flow Statement Financials | |
$-62.77M |
|
$-13.15M |
|
$270.48M |
|
|
Beginning Cash |
$56.91M |
$251.46M |
|
$194.55M |
|
$13.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
36.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-63.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.26% |
|
-5.26% |
|
-5.03% |
|
-5.26% |
|
$10.74 |
|
$-1.67 |
|
$-1.65 |
|